Education
About Us
Working with TipRanks
Follow Us
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.44M |
| Gross Profit | $ 0.00 | $ 0.00 | $ -169.00K | $ -12.30M | $ -6.56M |
| Operating Income | $ -114.02M | $ -61.14M | $ -45.24M | $ -19.58M | $ -7.91M |
| EBITDA | $ -98.08M | $ -51.61M | $ -42.69M | $ -19.58M | $ -7.91M |
| Net Income | $ -102.33M | $ -52.37M | $ -42.86M | $ -100.61M | $ -7.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 171.56M | $ 243.52M | $ 177.60M | $ 194.24M | $ 43.78M |
| Total Assets | $ 238.99M | $ 310.13M | $ 196.59M | $ 230.33M | $ 44.43M |
| Total Debt | $ 29.70M | $ 28.49M | $ 105.00K | $ 0.00 | $ 0.00 |
| Net Debt | $ -5.92M | $ -38.40M | $ -130.00M | $ -122.16M | $ -43.78M |
| Total Liabilities | $ 57.18M | $ 43.15M | $ 7.81M | $ 5.15M | $ 63.02M |
| Stockholders' Equity | $ 181.82M | $ 266.97M | $ 188.78M | $ 225.18M | $ -18.59M |
| Cash Flow | |||||
| Free Cash Flow | $ -86.23M | $ -43.09M | $ -35.31M | $ -18.00M | $ -7.45M |
| Operating Cash Flow | $ -86.22M | $ -43.06M | $ -35.15M | $ -17.96M | $ -7.45M |
| Investing Cash Flow | $ 48.03M | $ -171.67M | $ 39.19M | $ -104.12M | $ 0.00 |
| Financing Cash Flow | $ 6.93M | $ 151.75M | $ 3.91M | $ 200.47M | $ 44.67M |